JP2021523945A5 - - Google Patents
Info
- Publication number
- JP2021523945A5 JP2021523945A5 JP2021514456A JP2021514456A JP2021523945A5 JP 2021523945 A5 JP2021523945 A5 JP 2021523945A5 JP 2021514456 A JP2021514456 A JP 2021514456A JP 2021514456 A JP2021514456 A JP 2021514456A JP 2021523945 A5 JP2021523945 A5 JP 2021523945A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- composition according
- optionally
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018901672 | 2018-05-15 | ||
| AU2018901672A AU2018901672A0 (en) | 2018-05-15 | Activating Agents | |
| PCT/AU2019/050462 WO2019218015A1 (en) | 2018-05-15 | 2019-05-15 | Activating agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523945A JP2021523945A (ja) | 2021-09-09 |
| JP2021523945A5 true JP2021523945A5 (enExample) | 2022-05-24 |
| JP7644000B2 JP7644000B2 (ja) | 2025-03-11 |
Family
ID=68539125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514456A Active JP7644000B2 (ja) | 2018-05-15 | 2019-05-15 | 活性化剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12134663B2 (enExample) |
| EP (1) | EP3794015A4 (enExample) |
| JP (1) | JP7644000B2 (enExample) |
| KR (1) | KR20210021311A (enExample) |
| CN (1) | CN112368293A (enExample) |
| AU (1) | AU2019268411B2 (enExample) |
| CA (1) | CA3100072A1 (enExample) |
| WO (1) | WO2019218015A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3794014A4 (en) * | 2018-05-15 | 2022-03-16 | InterK Peptide Therapeutics Limited | PEPTIDE ACTIVATING AGENT |
| KR20210097729A (ko) * | 2018-11-30 | 2021-08-09 | 인터크 펩타이드 테라퓨틱스 리미티드 | 피부 병태를 개선하기 위한 폴리펩타이드 및 방법 |
| EP4244234A4 (en) * | 2020-11-10 | 2024-12-25 | InterK Peptide Therapeutics Limited | POLYPEPTIDES AND METHODS FOR IMPROVING SKIN DISEASES |
| EP4387672A4 (en) * | 2021-08-20 | 2025-10-15 | Interk Peptide Therapeutics Ltd | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING CANCER-ASSOCIATED AUTOIMMUNITY AND CANCER THERAPY |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1226552B (it) * | 1988-07-29 | 1991-01-24 | Ellem Ind Farmaceutica | Peptidi immunostimolanti. |
| US20030162956A1 (en) | 1997-04-07 | 2003-08-28 | Human Genome Sciences, Inc. | Leukocyte regulatory factors 1 and 2 |
| AUPR230500A0 (en) * | 2000-12-22 | 2001-01-25 | University Of Newcastle Research Associates Limited, The | A method of modulating map kinase mediated cellular activity and agents useful in same |
| US20030194798A1 (en) | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| DK1446489T3 (da) | 2001-10-15 | 2012-05-14 | Engeneic Molecular Delivery Pty Ltd | Intakte miniceller som vektorer for DNA-overførsel og genterapi in vitro og in vivo |
| US7611885B2 (en) | 2003-06-24 | 2009-11-03 | Engeneic Molecular Delivery Pty, Ltd. | Pharmaceutically compatible method for purifying intact bacterial minicells |
| WO2005009346A2 (en) | 2003-06-24 | 2005-02-03 | Mirus Corporation | Inhibition of gene function by delivery of polynucleotide-based gene expression inhibitors to mammalian cells in vivo |
| EP1689439A2 (en) | 2003-09-22 | 2006-08-16 | Acidophil LLC | Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| US20060194319A1 (en) | 2004-09-02 | 2006-08-31 | Webb Carol F | Promoter substitution for immunoglobulin therapy |
| WO2006029981A1 (en) | 2004-09-13 | 2006-03-23 | Vib Vzw | Abin-mediated protection against lung inflammatory disease |
| CN101094688B (zh) | 2004-09-13 | 2013-05-01 | 建新公司 | 多聚构建体 |
| US7429481B2 (en) | 2004-09-14 | 2008-09-30 | University Of Pittsburgh | Targeting viruses using a modified sindbis glycoprotein |
| JP5703466B2 (ja) | 2007-08-07 | 2015-04-22 | パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | キナーゼ阻害薬およびその使用 |
| ES2714200T3 (es) | 2007-09-18 | 2019-05-27 | Brightpath Biotherapeutics Co Ltd | Composición inductora de CTL |
| RS53872B2 (sr) | 2008-05-14 | 2018-06-29 | Immatics Biotechnologies Gmbh | Novi i snažni mhc peptidi klase ii izvedeni iz survivina i neurokana |
| AU2009324661A1 (en) | 2008-12-10 | 2011-07-07 | Purdue Research Foundation | Cell-permeant peptide-based inhibitor of kinases |
| AU2010215086A1 (en) | 2009-02-23 | 2011-09-08 | Inter-K Pty Limited | Inhibition of multiple cell activation pathways |
| US9580474B2 (en) | 2010-09-08 | 2017-02-28 | The Johns Hopkins University | Polyionic papilloma virus-like particle (VLP) vaccines |
| US20140186372A1 (en) * | 2011-06-16 | 2014-07-03 | La Jolla Institute For Allergy And Immunology | Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseases |
| WO2013033838A1 (en) | 2011-09-09 | 2013-03-14 | Pharmagap Inc. | Liposomal formulations of cationic peptides and uses thereof |
| JP6249447B2 (ja) | 2012-01-24 | 2017-12-20 | インターケー・ペプチド・セラピューティクス・リミテッド | 癌治療用ペプチド剤 |
| WO2015053338A1 (ja) * | 2013-10-08 | 2015-04-16 | 学校法人東京理科大学 | カチオン性ペプチドおよびそれを含む医薬組成物 |
| JP6367600B2 (ja) | 2014-04-18 | 2018-08-01 | 矢崎総業株式会社 | コネクタ |
| EP3634978A1 (en) * | 2017-06-07 | 2020-04-15 | Adrx, Inc. | Tau aggregation inhibitors |
-
2019
- 2019-05-15 CA CA3100072A patent/CA3100072A1/en active Pending
- 2019-05-15 AU AU2019268411A patent/AU2019268411B2/en active Active
- 2019-05-15 US US17/055,250 patent/US12134663B2/en active Active
- 2019-05-15 KR KR1020207036028A patent/KR20210021311A/ko active Pending
- 2019-05-15 EP EP19803532.1A patent/EP3794015A4/en not_active Withdrawn
- 2019-05-15 CN CN201980043872.7A patent/CN112368293A/zh active Pending
- 2019-05-15 WO PCT/AU2019/050462 patent/WO2019218015A1/en not_active Ceased
- 2019-05-15 JP JP2021514456A patent/JP7644000B2/ja active Active
-
2024
- 2024-09-27 US US18/899,187 patent/US20260103488A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7360419B2 (ja) | 安定化抗微生物性ペプチド | |
| JP2014521684A5 (enExample) | ||
| JP2021100937A5 (enExample) | ||
| JP2013500990A5 (enExample) | ||
| JP2008514586A5 (enExample) | ||
| RU2016110153A (ru) | Новые пептиды и их аналоги для применения при лечении мукозита полости рта | |
| RU2014140231A (ru) | Антимикробные пептиды | |
| JP2009534451A5 (enExample) | ||
| US20250215054A1 (en) | Compositions and methods for treatment of fungal infections | |
| JP2021523946A5 (enExample) | ||
| JPWO2022202816A5 (enExample) | ||
| HUT61036A (en) | Process for producing new polypeptides capable of linking to lipopolysaccharides and pharmaceutical compositions comprising same as active ingredients | |
| CN109232744A (zh) | 改进型齐考诺肽 | |
| CN109265556A (zh) | 一种适用于静脉、腹腔或鼻腔给药的多肽 | |
| EP2990415B1 (en) | Cyclic beta defensins analogs for the treatment of infections | |
| US20180201647A1 (en) | Peptoid | |
| EP3423471A1 (en) | Fusion respiratory syncytial virus inhibitors and use thereof | |
| CN111247162B (zh) | 多黏菌素类似物及其制备方法 | |
| JP2017500849A5 (enExample) | ||
| JPWO2018038168A1 (ja) | ヘマグルチニン結合ペプチド、および、これを含むインフルエンザウイルス感染症の予防・治療薬 | |
| JP2014198711A (ja) | Ｃｔ阻害４価ペプチドおよびコレラ治療薬 | |
| US12012440B2 (en) | Compositions and methods for treatment of fungal infections | |
| WO1997048725A1 (en) | Novel peptides for prevention and treatment of infection | |
| TW476650B (en) | Use of a cytokine regulatory agent to treat rheumatoid arthritis | |
| JPWO2008050830A1 (ja) | 抗ｈｉｖ剤 |